Quick answers
- What is Norgesic Forte?
- Norgesic Forte is a brand name of Orphenadrine citrate, aspirin and caffeine, a prescription medicine. The FDA NDC Directory lists 1 Norgesic Forte product in 1 strength and form.
- Who makes Norgesic Forte?
- Galt Pharms holds the FDA application for Norgesic Forte (ANDA075141, approved May 29, 1998).
- Is there a generic or store brand of Norgesic Forte?
- Other products of Orphenadrine citrate, aspirin and caffeine are listed with the FDA, but none in exactly the same strength and form as a Norgesic Forte product.
- Has Norgesic Forte been recalled?
- No recall linked to Norgesic Forte products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Norgesic Forte is
Each Norgesic Forte product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Orphenadrine citrate, aspirin and caffeine · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| aspirin 770 mg · caffeine 60 mg · orphenadrine citrate 50 mg tablet, multilayer (oral) | Norgesic Forte | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Orphenadrine citrate, aspirin and caffeine →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA075141 | Galt Pharms | May 29, 1998 | 1 |
Companies that list Norgesic Forte
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Norgesic Forte products.
- Poly Pharmaceuticals, Inc.1 product
Recalls
No recall linked to Norgesic Forte products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.